DE602006016952D1 - Cnf1 bacterielles toxin-protein aus e. coli als analgetikum - Google Patents
Cnf1 bacterielles toxin-protein aus e. coli als analgetikumInfo
- Publication number
- DE602006016952D1 DE602006016952D1 DE602006016952T DE602006016952T DE602006016952D1 DE 602006016952 D1 DE602006016952 D1 DE 602006016952D1 DE 602006016952 T DE602006016952 T DE 602006016952T DE 602006016952 T DE602006016952 T DE 602006016952T DE 602006016952 D1 DE602006016952 D1 DE 602006016952D1
- Authority
- DE
- Germany
- Prior art keywords
- coli
- cnf1
- analgetic
- toxin protein
- bacterial toxin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/164—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pain & Pain Management (AREA)
- Epidemiology (AREA)
- Hospice & Palliative Care (AREA)
- Emergency Medicine (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Psychiatry (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Materials For Medical Uses (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT000422A ITRM20050422A1 (it) | 2005-08-05 | 2005-08-05 | Fattori proteici dermonecrotizzanti di origine batterica e relativi usi in campo medico. |
PCT/IT2006/000596 WO2007017914A2 (en) | 2005-08-05 | 2006-08-03 | Dermonecrotizing protein factors of bacterial origin and related uses in medical field |
Publications (1)
Publication Number | Publication Date |
---|---|
DE602006016952D1 true DE602006016952D1 (de) | 2010-10-28 |
Family
ID=37663127
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE602006016952T Active DE602006016952D1 (de) | 2005-08-05 | 2006-08-03 | Cnf1 bacterielles toxin-protein aus e. coli als analgetikum |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP1909816B1 (de) |
AT (1) | ATE481107T1 (de) |
DE (1) | DE602006016952D1 (de) |
IT (1) | ITRM20050422A1 (de) |
WO (1) | WO2007017914A2 (de) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1398191B1 (it) * | 2010-02-17 | 2013-02-14 | Ist Superiore Sanita | Uso di tossine che attivano le rho gtpasi per il trattamento e/o la prevenzione della sintomatologia associata alla sindrome di rett (rtt). |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1420783A (zh) * | 1999-10-04 | 2003-05-28 | 维昂药品公司 | 用于将效应分子定向递送至肿瘤的组合物及方法 |
US6500436B2 (en) * | 2000-01-19 | 2002-12-31 | Allergan, Inc. | Clostridial toxin derivatives and methods for treating pain |
EP1570856A3 (de) * | 2004-02-26 | 2005-10-12 | Institut National De La Sante Et De La Recherche Medicale (Inserm) | Eine Impfstoffzusammensetzung, die ein Immunoadjuvants-Verbindung bestehend aus einem RHO GTPase-Aktivator. |
EP1580195A1 (de) * | 2004-03-26 | 2005-09-28 | Mutabilis SA | Zusammensetzungen von Polypeptiden spezifisch für pathogene ExPEC E. coli, sowie deren Anwendung als Vakzine und in der Immuntherapie |
GB0506797D0 (en) * | 2005-04-04 | 2005-05-11 | Istituto Superiore Di Sanito | Treatment of cognitive and learning impairment |
-
2005
- 2005-08-05 IT IT000422A patent/ITRM20050422A1/it unknown
-
2006
- 2006-08-03 DE DE602006016952T patent/DE602006016952D1/de active Active
- 2006-08-03 AT AT06796248T patent/ATE481107T1/de not_active IP Right Cessation
- 2006-08-03 EP EP06796248A patent/EP1909816B1/de not_active Not-in-force
- 2006-08-03 WO PCT/IT2006/000596 patent/WO2007017914A2/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
EP1909816A2 (de) | 2008-04-16 |
ITRM20050422A1 (it) | 2007-02-06 |
EP1909816B1 (de) | 2010-09-15 |
ATE481107T1 (de) | 2010-10-15 |
WO2007017914A2 (en) | 2007-02-15 |
WO2007017914A3 (en) | 2007-05-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA200701918A1 (ru) | Белок липокалин | |
MX2009006651A (es) | Antagonistas de activina-actrii y usos para incrementar los niveles de globulos rojo. | |
TW200732349A (en) | Anti-OX40L antibodies and methods using same | |
EA200900781A1 (ru) | 4-фенилпиран-3,5-дионы, 4-фенилтиопиран-3,5-дионы и циклогексантрионы, как новые гербициды | |
CY1113188T1 (el) | Τροποποιημενα fgf-21 πολυπεπτιδια και οι χρησεις τους | |
DK1804589T3 (da) | Fedtsammensætninger | |
MX354100B (es) | Formulaciones de proteinas y metodos para elaborarlas. | |
TW200806317A (en) | Methods for reducing protein aggregation | |
TW200715969A (en) | Fungicidal active-compound combination | |
ATE481984T1 (de) | Vakzine-peptid-kombinationen gegen katzenallergie | |
ATE484509T1 (de) | Antibakterielle mittel | |
CY1113770T1 (el) | Κυκλικα αντι-μικροβιακα πεπτιδια | |
WO2007053512A3 (en) | Novel protein transduction domains and uses therefor | |
TW200738751A (en) | Anti-EphrinB2 antibodies and methods using same | |
ATE452646T1 (de) | Zusammensetzungen mit epigallocatechingallat und proteinhydrolysat | |
UA92593C2 (ru) | Лечение мастита энрофлоксацином | |
SE0301650D0 (sv) | Novel compounds | |
DK1713438T3 (da) | Medicinsk sæbe | |
ATE499341T1 (de) | 5-(2,2-dimethyl-cyclopropyl)-3-methylpent-2- ennitril als geruchs- und geschmacksstoff | |
DE602006016952D1 (de) | Cnf1 bacterielles toxin-protein aus e. coli als analgetikum | |
CY1110942T1 (el) | Αλας αιθανολαμινης n-(3-μεθοξυ-αιθοξυ-5-μεθυλπυραζιν-2-υλ)-2-(4-[1,3,4-οξαδιαζολο -2-υλ]φαινυλ)πυριδινο-3-σουλφοναμιδιου | |
WO2005108563A3 (en) | Peptidoglycan-hydrolyzing protein encoded by bacteriophage n4 | |
NO20084671L (no) | Peptidforbindelse med biologisk aktivite, dets tillaging og dets anvedelser | |
DE602007010502D1 (de) | ||
UA2492U (uk) | Штам бактерій escherichia coli hm-2 для виготовлення бактерійних препаратів |